MedTrace Logo

Efficacy and Safety Study of Ticagrelor

NCT01812330 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2015-06-24

No results posted yet for this study

Summary

The purpose of this study is to compare the efficacy and safety of ticagrelor with clopidogrel

Conditions

  • Acute Coronary Syndrome

Interventions

DRUG

Clopidogrel

After 600mg loading dose, 75mg or 150mg Qd

DRUG

Ticagrelor

90mg Bid

Sponsors & Collaborators

  • General Hospital of Chinese Armed Police Forces

    lead OTHER

Principal Investigators

  • huiliang liu, doctor · Department of Cardiology of General Hospital of Chinese People's Armed Police Forces

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2015-12-31
Completion
2016-07-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01812330 on ClinicalTrials.gov